Navigation Links
BioNanomatrix Founder and CSO Dr. Han Cao Awarded Chinese Rising Star Entrepreneur Award
Date:10/7/2010

PHILADELPHIA, Oct. 7 /PRNewswire/ -- BioNanomatrix, Inc., which is developing and commercializing breakthrough single-molecule genomic analysis technology, announced today that Founder and Chief Scientific Officer, Han Cao, Ph.D., was awarded the Chinese Rising Star Entrepreneur Award at the China International Economic and Technical Cooperation Forum in Beijing, China on September 27, 2010.  The award is in recognition of Dr. Cao's entrepreneurial spirit and success in the founding of BioNanomatrix and the development of the Company's novel genomic analysis technology.  

Commenting on the milestone, Edward L. Erickson BioNanomatrix's president and chief executive officer, said: "This is a very great honor for Han and for the company he founded, BioNanomatrix.  We believe that the largest country markets for our products are the USA and China, with China rapidly becoming a world leader in genomics and life science research generally.  We look forward to mutually beneficial collaboration with Chinese research institutions and scientists as we commercialize our revolutionary technology."

About BioNanomatrix

BioNanomatrix, Inc., a privately held genomics company, is developing and commercializing game-changing, proprietary technologies for analysis of large biological molecules, such as nucleic acids that are extremely important in life science research, clinical diagnostic applications, and development of new therapeutics.  This technology is designed to reduce dramatically the time and complexity to analyze the genome.  BioNanomatrix's products will provide users with the means to perform single-molecule analyses on minute biological samples that are essentially impossible, impractical or too expensive with current technology.  For more information, visit: www.bionanomatrix.com.

Note: NANOANALYZER is a registered trademark of BioNanomatrix, Inc. The names of other companies, other entities, products and/or services mentioned herein may be the trademarks of their respective owners. Media Contact:  Tiberend Strategic Advisors, Inc. (212) 827-0020 Farrell Denbyfdenby@tiberendstrategicadvisors.com   orAndrew Mielach amielach@tiberendstrategicadvisors.com  
'/>"/>

SOURCE BioNanomatrix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioNanomatrix Announces Appointment of Dr. Pui-Yan Kwok to Its Scientific Advisory Board
2. BioNanomatrix Appoints Michael Kochersperger as Vice President of Engineering
3. BioNanomatrixs Revolutionary Whole Genome Analysis Platform Named to MIT Technology Reviews Annual 10 Emerging Technologies List
4. BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L. Barker as Advisers
5. BioNanomatrix Awarded Supplemental Funding to Accelerate Commercialization of Innovative Single-Molecule Analyzer
6. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
7. SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY
8. Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders
9. Fina Technologies Names Spotfire Founder Christopher Ahlberg to Board of Directors
10. Amylin Co-Founder Announces Plans to Vote for Eastbourne Slate
11. Scripps Research Institute Highlights Groundbreaking Work of aTyr Pharma Scientific Co-Founder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... ... Services (NYS DFS) cybersecurity regulations have transitioned into full force and ... operating in the state (“Covered Entities”) to conduct an annual, professional, comprehensive ...
(Date:9/18/2017)... ... September 18, 2017 , ... ... the move of the SPIE Digital Library ( http://www.spiedigitallibrary.org ) on 15 August ... create an improved user experience and incorporate a number of enhancements and new ...
(Date:9/17/2017)... ... , ... GeneOne Life Science, Inc. announces that it has ... for an Investigational New Drug application for a Phase I/IIa study of its ... in Korea represents the second clinical trial for GLS-5300. , A US ...
(Date:9/14/2017)... Philadelphia PA and London UK (PRWEB) , ... ... ... company, will gather the most innovative minds in pharma and biotech at the ... is a two-day collaborative conference that brings together the world’s most progressive clinical ...
Breaking Biology Technology:
(Date:4/11/2017)... April 11, 2017 Crossmatch®, a globally-recognized ... solutions, today announced that it has been awarded ... Projects Activity (IARPA) to develop next-generation Presentation Attack ... "Innovation has been a driving force within ... will allow us to innovate and develop new ...
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
Breaking Biology News(10 mins):